Uses of polypills for cardiovascular disease and evidence to date

Polypills have been approved in more than 30 countries, but worldwide experience with and availability of polypills remain limited, unlike fixed-dose combinations in other diseases such as HIV, tuberculosis, and malaria. In this Series review, we aim to propose a guide for the use of polypills in fu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) Jg. 389; H. 10073; S. 1055 - 1065
Hauptverfasser:	Huffman, Mark D, Xavier, Denis, Perel, Pablo
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Elsevier Ltd 11.03.2017 Elsevier Limited
Schlagworte:	Atherosclerosis Cardiovascular disease Cardiovascular diseases Disease prevention Drug dosages Drug therapy Health risk assessment Heterogeneity Internal Medicine Lipids Malaria Pharmaceutical industry Prevention Purchasing contracts Risk assessment Risk factors Studies Tuberculosis Vector-borne diseases
ISSN:	0140-6736, 1474-547X, 1474-547X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!